| 发明名称 |
Use of N-(dibenz(B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine or a pharmaceutically acceptable addition salt thereof for the prophylaxis and/or treatment of muscular dystrophy |
| 摘要 |
The invention relates to the use of a compound of the formula (I) or a pharmaceutically acceptable addition salt thereof for the preparation of a medicament for the prophylaxis and/or treatment of muscular dystrophy.
|
| 申请公布号 |
US2010160269(A1) |
申请公布日期 |
2010.06.24 |
| 申请号 |
US20060063268 |
申请日期 |
2006.08.22 |
| 申请人 |
SANTHERA PHARMACEUTICALS (SCHWEIZ) AG |
发明人 |
MEIER THOMAS;RUEGG MARKUS A. |
| 分类号 |
A61K31/335;A61K31/56;A61P21/00 |
主分类号 |
A61K31/335 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
